Clinical Trials at Women and Infants Hospital
As of August 2026, 25 paid clinical trials are recruiting at Women and Infants Hospital, located at 101 DUDLEY ST, PROVIDENCE, RI 02905-2401, phone (401) 274-1100 in Providence, Rhode Island. Active studies at this site cover conditions such as Advanced Solid Tumor, Crohn's Disease and Endometrial Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
25 clinical trials at Women and Infants Hospital
·Clear filters·Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
E-Mindfulness Approaches for Living After Breast Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
RCT of Pain Perception With Fast and Slow Tenaculum Application
Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection
Cardiovascular Protection After Preeclampsia With Enalapril
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Common conditions studied in Providence
- Advanced Solid Tumor (9 active studies)
- Crohn's Disease (8 active studies)
- Endometrial Cancer (8 active studies)
- Ulcerative Colitis (8 active studies)
- Acute Myeloid Leukemia (7 active studies)
- Alcohol Use Disorder (7 active studies)
Leading research sponsors in Providence
- Brown University
- Rhode Island Hospital
- National Cancer Institute (NCI)
- Women and Infants Hospital of Rhode Island
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Providence?
There are approximately 415 recruiting clinical trials in Providence, Rhode Island listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Providence pay participants?
Most recruiting trials in Providence compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Providence?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Providence?
The most common conditions under active study in Providence include Advanced Solid Tumor (9), Crohn's Disease (8), Endometrial Cancer (8), Ulcerative Colitis (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Providence?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Providence on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Providence?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Providence?
Recruiting research sites in Providence include Rhode Island Hospital, Brown University, Women and Infants Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Providence right now?
The largest active categories in Providence are Cancer & tumors (138), Neurology & pain (24), Cardiovascular (24). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Women and Infants Hospital?
Women and Infants Hospital is located at 101 DUDLEY ST, PROVIDENCE, RI 02905-2401. Use the Google Maps link in the intro above to get directions.
How do I contact Women and Infants Hospital?
You can reach Women and Infants Hospital by phone at (401) 274-1100. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.